Mara Dinsmoor, MD, MPHDepartment of Obstetrics and Gynecology
Director of Research

Education

  • Undergraduate:
    • AB, Biochemistry, Dartmouth
    • MPH, Virginia Commonwealth University
  • Medical School: MD, Indiana University School of Medicine
  • Residency: Obstetrics and Gynecology, University of Vermont
  • Fellowship: Maternal-Fetal Medicine, University of Texas HSC, San Antonio

Research Interests

Outcomes research; infectious disease in pregnancy

Honors and Awards

  • Alpha Omega Alpha Honor Society
  • Humana/SPO Award for Excellence in Clinical Research, 1992
  • Citation in Best Doctors in the America

Professional Memberships/Affiliations/Activities

  • Fellow, American College of Obstetricians and Gynecologists
  • Board Examiner, American Board of Obstetrics and Gynecology
  • Member, Society for Maternal-Fetal Medicine
  • Member, Infectious Disease Society for Obstetrics-Gynecology

Scholarly Work

Publications in Peer-Review Journals:

  1. Jackson SL, O’Connell NG, Borzelleca JF, Dinsmoor MJ, Soper DE. Cervicitis as a clinical indicator of gonococcal and chlamydial infections in pregnancy. Infectious Diseases in Obstetrics and Gynecology 3:184-188, 1996.
  2. Schuchat A, Zywicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O’Sullivan MJ, Patel D, Peters MT, Stoll B, Levine OS, and the Prevention of Early-onset Neonatal Sepsis (ENS) Study Group. Risk factors and opportunities for prevention of early-onset neonatal sepsis: A multicenter case-control study. Pediatrics 105:21-6, 2000.
  3. Diaz LM, Lin P, Dinsmoor MJPreventable risk factors for the delivery of very low birthweight infants in Richmond, Virginia. Primary Care Update for OB/GYNs 8:1-4, 2001.
  4. Dinsmoor MJ and Seeds JW. Fetal urethral obstruction with spontaneous rupture of the bladder and creation of gastroschisis. Journal of Ultrasound in Medicine. 21:577-9, 2002.
  5. Dinsmoor MJ and Forrest ST.  The use of protease inhibitors in pregnancy does not increase the likelihood of an abnormal glucola test result.  Infectious Diseases in Ob/Gyn 2002;10:187-91.
  6. Dinsmoor MJ.  Prophylactic antibiotics in labor and delivery.  ACOG Practice Bulletin #47.  Obstet Gynecol 2003;102:875-82.
  7. Dinsmoor MJ, Bachman R, Haney EI, Goldstein M, MacKendrick W.  Outcomes Following Expectant Management of Extremely Preterm Premature Rupture of the Membranes.  Am J Obstet Gynecol 2004:190:183-7.
  8. Dinsmoor MJ and Brock EL.  Predicting failed trial of labor after cesarean delivery.  Obstet Gynecol 2004;103:282-8.
  9. Dinsmoor, MJ.  Group B Streptococcus:  A culture-based prevention strategy.  The Female Patient.  2004;29:24-30.
  10. Dinsmoor, MJ.  Should pregnant patients be worried about West Nile virus?  Contemp Obstet Gynecol; 2004;49:66-75.
  11. Dinsmoor, MJ.  Infectious diarrhea.  Contemp Obstet Gynecol; in press.
  12. Dinsmoor MJ and Gilstrap JE.  "Infection Control."  In: Operative Obstetrics, 2nd edition.  Gilstrap et al, editors.  New York:  The McGraw-Hill Companies, 2002.
  13. Dinsmoor, MJ.  Maternal Disease: Group B Streptococcus.  In Management of High Risk Pregnancy, 5th edition.  Queenan, JT.  In press.
× Alternate Text